Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT

Potential efficacy of dopaminergic antidepressants in treatment resistant anergic-anhedonic depression results of the chronic anergic-anhedonic depression open trial – CADOT

IntroductionAmong treatment-resistant depression (TRD), we identified anergic-anhedonic clinical presentations (TRAD) as putatively responsive to pro-dopaminergic strategies. Based on the literature, non-selective monoamine oxidase inhibitors (MAOI) and dopamine D2 receptor agonists (D2RAG) were seq...

Full description

Bibliographic Details
Main Authors: Ludovic Christophe Dormegny-Jeanjean, Clément de Billy, Olivier Mainberger, Sébastien Weibel, Benoit Schorr, Alexandre Obrecht, Lionel Landré, Fabrice Berna, Jean-Baptiste Causin, Frederic Blanc, Vlad Danila, Mihaela Tomsa, Geraldine Pfleger, Camille Meyer, Ilia Humbert, Hervé Javelot, Guillaume Meyer, Gilles Bertschy, Jack Rene Foucher
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Psychiatry
Subjects:
treatment resistant depression
anergia
anhedonia
apathy
monoamine oxidase inhibitors
dopamine D2 receptor agonists
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1194090/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2023.1194090/full

Similar Items